- Home
- WBX vs SNTI Comparison
WBX vs SNTI Comparison
Compare WBX & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBX
- SNTI
- Stock Information
- Founded
- WBX 2015
- SNTI 2016
- Country
- WBX Spain
- SNTI United States
- Employees
- WBX N/A
- SNTI N/A
- Industry
- WBX Industrial Specialties
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- WBX Consumer Discretionary
- SNTI Health Care
- Exchange
- WBX Nasdaq
- SNTI Nasdaq
- Market Cap
- WBX 92.2M
- SNTI 85.3M
- IPO Year
- WBX N/A
- SNTI N/A
- Fundamental
- Price
- WBX $0.36
- SNTI $5.00
- Analyst Decision
- WBX Buy
- SNTI Strong Buy
- Analyst Count
- WBX 3
- SNTI 1
- Target Price
- WBX $0.83
- SNTI $12.00
- AVG Volume (30 Days)
- WBX 443.9K
- SNTI 22.5K
- Earning Date
- WBX 05-07-2025
- SNTI 05-08-2025
- Dividend Yield
- WBX N/A
- SNTI N/A
- EPS Growth
- WBX N/A
- SNTI N/A
- EPS
- WBX N/A
- SNTI N/A
- Revenue
- WBX $169,730,821.00
- SNTI N/A
- Revenue This Year
- WBX $0.51
- SNTI N/A
- Revenue Next Year
- WBX $38.01
- SNTI N/A
- P/E Ratio
- WBX N/A
- SNTI N/A
- Revenue Growth
- WBX 14.03
- SNTI N/A
- 52 Week Low
- WBX $0.25
- SNTI $1.52
- 52 Week High
- WBX $1.64
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- WBX 50.14
- SNTI 77.17
- Support Level
- WBX $0.34
- SNTI $3.50
- Resistance Level
- WBX $0.36
- SNTI $4.10
- Average True Range (ATR)
- WBX 0.04
- SNTI 0.38
- MACD
- WBX 0.01
- SNTI 0.20
- Stochastic Oscillator
- WBX 72.64
- SNTI 95.87
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.